Harpoon Therapeutics, Inc. (HARP) has a market capitalization of $865.08M and trades at $23.01. The 52-week range is 3.11-23.21.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -1.1, Earnings Per Share (EPS) of $-20.24, annual revenue of $31.92M.
The stock has a beta of 1.55, operates in the Healthcare sector.
